Back to T-Cell Childhood Acute Lymphocytic Leukemia

T-Cell Childhood Acute Lymphocytic Leukemia — Clinical Trials

MONDO:00008712 active·1 recruitingLast updated: Mar 16, 2026, 5:12 AM

Trial Landscape

T-Cell Childhood Acute Lymphocytic Leukemia has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

By Approach

Drug Treatment1

Procedure1

Biological Therapy1

By Phase

Phase 1

Phase 2

Phase 3

Sponsor Types

NIH1Academic/Other1

Trial Locations

United States1 trial

Australia1 trial

Canada1 trial

New Zealand1 trial

China1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

2 Trials

Phase 1Recruiting

NCT06420076

Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells

Sponsor:Essen Biotech

ChinaStarted: Jul 2024Est. completion: Dec 2026Updated: Nov 2024

Phase 3Active, Not Recruiting

NCT02112916

Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Oct 2014Est. completion: Sep 2026Updated: Dec 2025

Stay informed about clinical trials for T-Cell Childhood Acute Lymphocytic Leukemia.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 16, 2026 at 5:12 AM